Home › NDC Lookup › RxCUI directory › RxCUI 2665282

Hydroxychloroquine sulfate 200 MG Oral Tablet [Sovuna] — RxCUI 2665282

Name: Hydroxychloroquine sulfate 200 MG Oral Tablet [Sovuna] (RxCUI 2665282)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 2665282 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 5 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2665282

Official nameHydroxychloroquine sulfate 200 MG Oral Tablet [Sovuna]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known asSovuna 200 MG Oral Tablet

FDA products mapped2

Package NDCs mapped5

Reported Medicaid activity (SDUD)405 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Hydroxychloroquine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Hydroxychloroquine treats and prevents malaria, and treats rheumatoid arthritis, systemic lupus and chronic discoid lupus in adults. Your prescriber chose it for your specific cond...
Take it by mouth with food or milk, and swallow the tablet without crushing it. For lupus or arthritis it is usually daily. For malaria prevention it is weekly on the same day, sta...
Stomach upset is the most common, including nausea, vomiting, diarrhea and belly pain. Taking it with food can help. Call us if side effects are severe or don't settle.
Yes. Hydroxychloroquine can cause permanent retinal damage, especially with higher doses, longer use or kidney problems. A baseline eye exam in the first year is recommended, then...

📖 Read our full Hydroxychloroquine guide →

🕸️ Concept Web — How Hydroxychloroquine sulfate 200 MG Oral Tablet [S... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Hydroxychloroquine sulfate 200 MG Oral Tablet [Sovuna] RxCUI 2665282 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 2

The active substance itself — no strength, form, or brand attached yet.
- Hydroxychloroquine 5521 IN
- Hydroxychloroquine sulfate 153972 PIN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Sovuna 2665276 BN
Dose forms 13

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Hydroxychloroquine Oral Tablet 370656 SCDF
- Hydroxychloroquine sulfate Oral Tablet 2649121 SCDFP
- Hydroxychloroquine Oral Product 1164627 SCDG
- Hydroxychloroquine Pill 1164628 SCDG
- Hydroxychloroquine sulfate Oral Product 2661735 SCDGP
- Hydroxychloroquine sulfate Pill 2662514 SCDGP
- Hydroxychloroquine Oral Tablet [Sovuna] 2665280 SBDF
- Hydroxychloroquine sulfate Oral Tablet [Sovuna] 2665281 SBDFP
- +5 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Hydroxychloroquine sulfate 200 MG Oral Tablet 979092 SCD
- Hydroxychloroquine sulfate 200 MG 979091 SCDC
- Hydroxychloroquine sulfate 200 MG [Sovuna] 2665277 SBDC

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Hydroxychloroquine sulfate 200 MG Oral Tablet SCD · 979092
Hydroxychloroquine sulfate 200 MG SCDC · 979091
Hydroxychloroquine Oral Tablet SCDF · 370656
Hydroxychloroquine sulfate Oral Tablet SCDFP · 2649121
Hydroxychloroquine Oral Product SCDG · 1164627
Hydroxychloroquine Pill SCDG · 1164628
Hydroxychloroquine sulfate Oral Product SCDGP · 2661735
Hydroxychloroquine sulfate Pill SCDGP · 2662514

Brand-Name Concepts

Hydroxychloroquine sulfate 200 MG [Sovuna] SBDC · 2665277
Hydroxychloroquine Oral Tablet [Sovuna] SBDF · 2665280
Hydroxychloroquine sulfate Oral Tablet [Sovuna] SBDFP · 2665281
Sovuna Oral Product SBDG · 2665278
Sovuna Pill SBDG · 2665279
Sovuna BN · 2665276

📦 FDA Products & Package NDCs

2 products · 5 package NDCs

5 package NDCs map to RxCUI 2665282 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
70954-0804-10	30 TABLET, FILM COATED in 1 BOTTLE (70954-804-10)	SOVUNA	ANI Pharmaceuticals, Inc.	2023-09-15
70954-0804-20	100 TABLET, FILM COATED in 1 BOTTLE (70954-804-20)	SOVUNA	ANI Pharmaceuticals, Inc.	2023-09-15
70954-0804-30	14 TABLET, FILM COATED in 1 BOTTLE (70954-804-30)	SOVUNA	ANI Pharmaceuticals, Inc.	2023-09-15
70954-0805-10	100 TABLET, FILM COATED in 1 BOTTLE (70954-805-10)	SOVUNA	ANI Pharmaceuticals, Inc.	2023-09-15
70954-0805-20	14 TABLET, FILM COATED in 1 BOTTLE (70954-805-20)	SOVUNA	ANI Pharmaceuticals, Inc.	2023-09-15

Observed labelers: ANI Pharmaceuticals, Inc. (5) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.